GSK to buy US cancer treatment firm Nuvalent for $10.6bn ⊖⊖
found
a story from The Guardian ⚠️ › International
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
since
auto-detected in 6 stories
39 hours ago
found
a story from The Guardian ⚠️ › International
British drugmaker’s new chief executive Luke Miels announces one of its biggest deals
Business live – latest updates
GSK’s new boss Luke Miels has struck one of the British drugmaker’s biggest deals, a…
59 days ago
found
a story from The Guardian ⚠️ › International
Mo-Rez reduced or eliminated tumours in over 60% of patients and is expected to be a blockbuster drug
GSK has revealed positive results for a treatment for gynaecological cancers as its chief executiv…
3 months ago
4 months ago
New boss Luke Miels knows perils of overpromising but there is growing sense pharma firm is closer to filling potential
It’s a miracle. A mere 25 years after Glaxo Wellcome and SmithKline Beecham merg…
8 months ago
found
Rolling coverage of the latest economic and financial news, as GSK has appointed a new boss after announcing the departure of Dame Emma Walmsley.
GSK’s Emma Walmsley to be replaced as chief executive
I…
page 1 of 1